These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 32102637)
1. The implications of the PEPTIC trial for clinical practice. Young PJ; Bagshaw SM; Bellomo R; Nichol AD; Wright SE Crit Care Resusc; 2020 Mar; 22(1):4-5. PubMed ID: 32102637 [No Abstract] [Full Text] [Related]
2. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis]. Zhou JF; Wan XY; Huang W; Han LL Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466 [TBL] [Abstract][Full Text] [Related]
3. Stress Ulcer Prophylaxis: Who, When, and Why Stress Out About It? Larson A; Ahrndt S; Jansen T S D Med; 2016 Apr; 69(4):176-7. PubMed ID: 27263167 [No Abstract] [Full Text] [Related]
4. Stress ulcer prophylaxis: friend or foe? Macdonald JJ; Roberts JC; Washington S Br J Hosp Med (Lond); 2012 Apr; 73(4):238. PubMed ID: 22585209 [No Abstract] [Full Text] [Related]
5. Q: do all hospitalized patients need stress ulcer prophylaxis? Eisa N; Bazerbachi F; Alraiyes AH; Alraies MC Cleve Clin J Med; 2014 Jan; 81(1):23-5. PubMed ID: 24391103 [No Abstract] [Full Text] [Related]
6. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. ; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977 [TBL] [Abstract][Full Text] [Related]
8. Concordance between use of proton pump inhibitors and prescribing guidelines. Leditschke IA; Coombes JA Med J Aust; 2000 Jun; 172(11):564. PubMed ID: 10920757 [No Abstract] [Full Text] [Related]
9. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Krag M; Perner A; Wetterslev J; Møller MH Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933 [TBL] [Abstract][Full Text] [Related]
10. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol. Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM; Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780 [TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630 [TBL] [Abstract][Full Text] [Related]
12. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. Cook D; Guyatt G N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497 [No Abstract] [Full Text] [Related]
13. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers. Grindlinger GA; Cairo SB; Duperre CB J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335 [TBL] [Abstract][Full Text] [Related]
14. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists. Daure E; Ross L; Webster CR J Am Anim Hosp Assoc; 2017; 53(1):11-23. PubMed ID: 27841679 [TBL] [Abstract][Full Text] [Related]
15. Stress Ulcer Prophylaxis. Barletta JF; Bruno JJ; Buckley MS; Cook DJ Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192 [TBL] [Abstract][Full Text] [Related]
16. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial. Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030 [TBL] [Abstract][Full Text] [Related]
17. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU. Boyd C; Hassig T; MacLaren R Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588 [TBL] [Abstract][Full Text] [Related]
18. What's new with stress ulcer prophylaxis in the ICU? Marker S; Krag M; Møller MH Intensive Care Med; 2017 Aug; 43(8):1132-1134. PubMed ID: 28238056 [No Abstract] [Full Text] [Related]
19. Drugs for peptic ulcer disease and GERD. Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368 [No Abstract] [Full Text] [Related]
20. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH. Tofil NM; Benner KW; Fuller MP; Winkler MK J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]